Viveve Medical (VIVE) Misses Q3 EPS by 8c, Beats on Revenues

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.50), $0.08 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $3.71 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• CareDx completes Naveris acquisition, adding cancer MRD testing